Cambridge Trust’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $72.2K | Hold |
335
| – | – | ﹤0.01% | 387 |
|
|
2023
Q4 | $86.7K | Hold |
335
| – | – | ﹤0.01% | 356 |
|
|
2023
Q3 | $86.1K | Hold |
335
| – | – | ﹤0.01% | 360 |
|
|
2023
Q2 | $95.4K | Sell |
335
-62
| -16% | -$17.7K | ﹤0.01% | 360 |
|
|
2023
Q1 | $110K | Hold |
397
| – | – | 0.01% | 338 |
|
|
2022
Q4 | $110K | Sell |
397
-2
| -0.5% | -$554 | ﹤0.01% | 350 |
|
|
2022
Q3 | $107K | Buy |
399
+2
| +0.5% | +$536 | 0.01% | 350 |
|
|
2022
Q2 | $81K | Buy |
397
+62
| +19% | +$12.7K | ﹤0.01% | 417 |
|
|
2022
Q1 | $71K | Sell |
335
-33
| -9% | -$6.99K | ﹤0.01% | 478 |
|
|
2021
Q4 | $88K | Buy |
+368
| New | +$88K | ﹤0.01% | 436 |
|